BioCentury
ARTICLE | Company News

Charles River, Luminex deal

January 9, 2006 8:00 AM UTC

LMNX granted CRL a license to use xMAP assay technology with CRL's Research Models and Services business segment. CRL will use the technology to develop the Multiplexed Fluorometric ImmunoAssay, for u...